Euroapi S.A.

Paris Stock Exchange EAPI.PA

Euroapi S.A. Net Cash Used For Investing Activities for the year ending December 31, 2023: USD -151.54 M

Euroapi S.A. Net Cash Used For Investing Activities is USD -151.54 M for the year ending December 31, 2023, a 15.39% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.

Euroapi S.A. Net Cash Used For Investing Activities for the year ending December 31, 2022 was USD -179.11 M, a -79.00% change year over year.
Euroapi S.A. Net Cash Used For Investing Activities for the year ending December 31, 2021 was USD -100.06 M, a 7.23% change year over year.
Euroapi S.A. Net Cash Used For Investing Activities for the year ending December 31, 2020 was USD -107.86 M, a -18.37% change year over year.
Euroapi S.A. Net Cash Used For Investing Activities for the year ending December 31, 2019 was USD -91.13 M.

Key data

Date	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure

Paris Stock Exchange: EAPI.PA

Euroapi S.A.

CEO	Mr. Ludwig De Mot
IPO Date	May 6, 2022
Location	France
Headquarters	15 Rue Traversiere
Employees	3,650
Sector	Health Care
Industries Pharmaceuticals

Description

Euroapi SA develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. The company was incorporated in 2021 and is based in Paris, France.

Key trends

Past 5 years